Bruce Walcheck

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Epidermal Growth Factor Receptor

Monoclonal Antibody

Endoplasmic Reticulum Stress

Top Venues

Journal for immunotherapy of cancer

Cancer immunology, immunotherapy : CII

Antibodies (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Anders W Matson, Rob Hullsiek, Kate J Dixon, Sam Wang, Anders J Lindstedt, Ryan R Friess, Shee Kwan Phung, Tanya S Freedman, Martin Felices, Emily N Truckenbrod, Jianming Wu, Jeffrey S Miller, Bruce Walcheck
Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cells. Journal for immunotherapy of cancer 12 (7) (2024)
Kristin M Snyder, Kate J Dixon, Zachary Davis, Martin Hosking, Geoffrey Hart, Melissa Khaw, Anders Matson, Ryan Bjordahl, Bryan Hancock, Soheila Shirinbak, Jeffrey S Miller, Bahram Valamehr, Jianming Wu, Bruce Walcheck
iPSC-derived natural killer cells expressing the FcγR fusion CD64/16A can be armed with antibodies for multitumor antigen targeting. Journal for immunotherapy of cancer 11 (12) (2023)
James D Dahlvang, Jenna Kelly Dick, Jules A Sangala, Philippa R Kennedy, Emily J Pomeroy, Kristin M Snyder, Juliette M Moushon, Claire E Thefaine, Jianming Wu, Sara E Hamilton, Martin Felices, Jeffrey S Miller, Bruce Walcheck, Beau R Webber, Branden S Moriarity, Geoffrey Thomas Hart
Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. Journal of immunology (Baltimore, Md. : 1950) (2023)
Judith Cruz Amaya, Bruce Walcheck, Julie Smith-Gagen, Vincent C Lombardi, Dorothy Hudig
Detection of Antibody-Dependent Cell-Mediated Cytotoxicity-Supporting Antibodies by NK-92-CD16A Cell Externalization of CD107a: Recognition of Antibody Afucosylation and Assay Optimization. Antibodies (Basel, Switzerland) 12 (3) (2023)
Frank Cichocki, Jodie P Goodridge, Ryan Bjordahl, Sajid Mahmood, Zachary B Davis, Svetlana Gaidarova, Ramzey Abujarour, Brian Groff, Alec Drake Witty, Hongbo Wang, Katie Tuininga, Behiye Kodal, Martin Felices, Gregory B Bonello, Janel Huffman, Thomas Dailey, Tom T Lee, Bruce Walcheck, Bahram Valamehr, Jeffrey S Miller
Dual-antigen targeted off-the-shelf NK cells show durable response and prevent antigen escape in lymphoma and leukemia. Blood (2022)
Elisa C Toffoli, Abdolkarim Sheikhi, Roeland Lameris, Lisa A King, Amanda A van Vliet, Bruce Walcheck, Henk M W Verheul, Jan Spanholtz, Jurriaan B Tuynman, Tanja D de Gruijl, Hans J van der Vliet
Enhancement of NK Cell Antitumor Effector Functions Using a Bispecific Single Domain Antibody Targeting CD16 and the Epidermal Growth Factor Receptor. Cancers 13 (21) (2021)
Kate J Dixon, Jianming Wu, Bruce Walcheck
Engineering Anti-Tumor Monoclonal Antibodies and Fc Receptors to Enhance ADCC by Human NK Cells. Cancers 13 (2) (2021)
Hallie M Hintz, Kristin M Snyder, Jianming Wu, Robert Hullsiek, James D Dahlvang, Geoffrey T Hart, Bruce Walcheck, Aaron M LeBeau
Simultaneous Engagement of Tumor and Stroma Targeting Antibodies by Engineered NK-92 Cells Expressing CD64 Controls Prostate Cancer Growth. Cancer immunology research 9 (11) (2021)
Hemant K Mishra, Jing Ma, Daniel Mendez, Robert Hullsiek, Nabendu Pore, Bruce Walcheck
Blocking ADAM17 Function with a Monoclonal Antibody Improves Sepsis Survival in a Murine Model of Polymicrobial Sepsis. International journal of molecular sciences 21 (18) (2020)
Hemant K Mishra, Nabendu Pore, Emil F Michelotti, Bruce Walcheck
Anti-ADAM17 monoclonal antibody MEDI3622 increases IFNγ production by human NK cells in the presence of antibody-bound tumor cells. Cancer immunology, immunotherapy : CII 67 (9) (2018)